REFERENCES
- American Autoimmune Related Diseases Association, Inc. 2018. Autoimmune disease statistics. Available at: https://www.aarda.org/news-information/statistics/#1488234345468-3bf2d325-1052.
- American Cancer Society. 2018, January 3. Economic impact of cancer. Available at: https://www.cancer.org/cancer/cancer-basics/economic-impact-of-cancer.html.
- Chang, A. L., and Y. Y. Chen. 2017. CARs: Synthetic immunoreceptors for cancer therapy and beyond. Trends in Molecular Medicine 23 (5):430–50. doi:10.1016/j.molmed.2017.03.002.
- Ellebrecht, C. T., V. G. Bhoj, A. Nace, et al. 2016. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease. Science 353 (6295):179–84. doi:10.1126/science.aaf6756.
- Franks, A. L., and J. E. Slansky. 2012. Multiple associations between a broad spectrum of autoimmune disease, chronic inflammatory diseases and cancer. Anticancer Research 32 (4):1119–36.
- Jecker, N. S., A. G. Wightman, A. R. Rosenberg, and D. S. Diekema. 2018. Ethical guidance for selecting clinical trials to receive limited space in an immunotherapy production facility. American Journal of Bioethics 18 (4):58–67.
- Julian, M. K. 2014. Autoimmune disease: Cost-effective care. Nursing Management 45 (11):24–29. doi:10.1097/01.NUMA.0000455740.32485.9c.
- Rosman, Z., Y. Shoenfeld, and G. Zandman-Goddard. 2013. Biologic therapy for autoimmune diseases: An update. BMC Medicine 11:88. doi:10.1186/1741-7015-11-88.
- U.S. Department of Health and Human Services, Office on Women's Health. 2017, April 28. Autoimmune diseases. Available at: https://www.womenshealth.gov/a-z-topics/autoimmune-diseases.
- Wilkins, O., A. M. Keeler, and T. R. Flotte. 2017. CAR T-cell therapy: Progress and prospects. Human Gene Therapy Methods 28 (2):61–66. doi:10.1089/hgtb.2016.153.